Custom Search
|
|
Ordering Ivig From A Secure Supply Channel
It’s been over three decades since immunologists confirmed the effectiveness of intravenous immune globulin (IVIG) in treating patients with immunodeficiency. Immune globulin, derived from pooled plasma collected from thousands of donors, contains antibodies against a broad spectrum of bacteria and viruses.It is used primarily to treat three categories of illnesses: primary immune deficiencies, autoimmune neuromuscular disorders and certain rheumatologic conditions. Today, IVIG orders are routinely placed by neurologists, rheumatologists, dermatologists, oncologists and transplant specialists. And with drug tampering and counterfeiting on the rise, it’s more important than ever that physicians and patients have confidence in their product’s pedigree. FFF Enterprises, Inc. is widely recognized as the most trusted distributor of biopharmaceuticals in the nation. FFF is currently the only distributor representing all six US-approved IVIG manufacturers, including the recently approved Gammaplex manufactured by Bio Products Laboratory (BPL). Customers who order IVIG from FFF do so with confidence, based on the company‘s track record of more than 21 counterfeit-free years in the biopharmaceuticals industry, a significant accomplishment. Recognizing that at the end of every transaction there is a patient waiting for the products it distributes, FFF has put a number of safeguards in place to secure its supply chain. As an industry leader, FFF Enterprises, Inc., has developed and implemented many innovative technologies that have helped transform distribution protocols among biopharmaceutical suppliers. The company’s first-of-its-kind Verified Electronic Pedigree™ (VEP) system electronically displays the chain of custody for every product it ships, and its LotTrack™ service tracks products by lot number and provides recall notification to those affected. Another example of FFF’s quality commitment is epitomized by its specialty pharmacy subsidiary, NuFACTOR, which was established to provide IVIG, coagulation factors and vaccines directly to patients. “We are creating a standard for safety and excellence that we hope will continue to have a positive influence on the industry as a whole,” states Patrick M. Schmidt, chief executive officer, FFF Enterprises, Inc. “Our customers recognize the value of channel integrity to their patients and their bottom lines.” Obviously, living with a chronic illness that requires ongoing intravenous medication is stressful, especially for patien Article Directory: http://www.articledashboard.com FFF Enterprises is the author of this article on IVIG. Find more information about Orders for IVIG here. |
|